Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2005-10-28 / Mol. Ther. 2006 Jan;13(1):221-8Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein
/in International Publications, Newcastle Disease Virus /von 2005-08-01 / Int. J. Oncol. 2005 Aug;27(2):377-84[Study of Newcastle disease virus killing hepatocellular carcinoma cells in vitro]
/in International Publications, Newcastle Disease Virus /von 2005-06-01 / Zhonghua Gan Zang Bing Za Zhi 2005 Jun;13(6):467-8[Induction of apoptosis in human hepatoma cell line SMMC7721 by Newcastle disease virus HN gene]
/in International Publications, Newcastle Disease Virus /von 2005-05-01 / Zhonghua Zhong Liu Za Zhi 2005 May;27(5):279-82Targeting vaccinia to solid tumors with local hyperthermia
/in Hyperthermia, International Publications, Newcastle Disease Virus /von 2005-04-01 / Hum. Gene Ther. 2005 Apr;16(4):435-44T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine
/in International Publications, Newcastle Disease Virus /von 2005-03-31 / Vaccine 2005 Mar;23(19):2439-53Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2005-03-01 / Cancer Gene Ther. 2005 Mar;12(3):295-303Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein
/in International Publications, Newcastle Disease Virus /von 2005-02-01 / Int. J. Oncol. 2005 Feb;26(2):431-9Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer
/in Hyperthermia, International Publications, Newcastle Disease Virus /von 2005-01-01 / J. Virol. 2005 Jan;79(1):581-91IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de